The top 5 pharmaceutical companies to watch in 2022
Against the backdrop of Covid-19, which continues to roll in fresh waves, the life sciences industry extends its hive of activity into 2022, with many new pharmaceutical companies rising and established companies expanding. This exciting trend promises to introduce new innovations to the market and increase life sciences recruitment as the best companies compete to make breakthroughs and revolutionise the sector.
With its significant growth during the past two decades, the pharmaceutical industry is further predicted to grow by $1.6 trillion in the next 3 years. This excelled expansion makes it difficult to keep an eye on all developments. However, Quanta is here to help and we’ve compiled the top 5 pharmaceutical companies worth watching this year.
Launched in 2020, AavantiBio is a start-up company that’s making fresh and broad strides in the pharmaceutical industry. Founded by accomplished gene therapy researchers out of the University of Florida, this company is producing a variety of innovative gene transfer therapies, which have the potential to become the next generation of life-changing medicines.
Set to change the trajectory of precision genetic medication, its approach starts with tackling Friedreich’s Ataxia and continues with a vision to expand to other therapeutic treatments for diseases.
In 2021, AavantiBio, based in the US, recruited industry veterans and new experts to lead the company into the future. It also formed partnerships with universities to propel its expansion in 2022.
eTheRNA is an innovative company that emerged out of Belgium’s Vrije Universiteit Brussel in 2013. It burst onto the scene with its TriMix mRNA technology, which is designed to trigger a superior immune response once a virus enters the body.
Now in 2022, eTheRNA plans to launch several trials for a third-generation Covid-19 vaccine that can be effective against a broad category of variants. The company will also continue its collaborated research with ConserV Bioscience to develop an HIV vaccine based on Covid-19 mRNA technology . eTheRNA stated that “if the product surpasses Phase II clinical studies, upscale may be needed.” The companies innovative nature means that it is set become a more prominent figure in the pharmaceutical world and is one to watch in 2022.
Novartis is a fantastic Swiss-based company that focuses on using innovative science and digital technologies to create transformative treatments in areas of great medical need.
In 2020, Novartis, a Swiss-based company, announced a $25 million commitment to address health inequalities in North America, reinforcing its vision to “improve and extend people’s lives.” With more than 108,000 employees from 140 nationalities working for this leading medicine company, Novartis plans for 2022 are to push forward with a potential medicine for Covid-19.
At the end of 2021, Massachusetts-based Biogen partnered with the ACRP in an effort to grow and expand the diversity of its clinical research workforce. This positive move is expected to advance the company’s position as a leader in the months to come, supporting research and development as it continues with its ground-breaking trials in treating Alzheimer’s disease. Using AI, Biogen plans to propel the pharma industry forward with the support of a diverse team of industry experts.
Gilead Sciences is a biopharmaceutical company advancing medicines to prevent and treat life-threatening diseases including HIV, viral hepatitis and cancer. The California-based company are the owners of over 20 drugs and treatments for ailments such as HIV/AIDS, COVID-19, liver diseases and more.
Gilead has spent years and billions of dollars trying to advance in the field of HIV and oncology. While the company has won awards for cancer drugs in the past, new advancements in HIV research for 2022 are critical for its success. Operating in more than 35 countries across the globe, Gilead’s plans for expansion revolve around its mission to improve Antiviral development and address urgent global needs. This year is set to be a breakout year for Gilead and they are touted to be one on the most innovative companies by the end of 2022.
Broaden your life sciences career with Quanta
Are you looking to take the next step in your life sciences career? Allow our team at Quanta to connect you to your next role. With our resources and dedication to pairing the best candidates with the best positions, including biopharmaceutical jobs and pharmacovigilance jobs, our mission is to contribute to the improvements of the health industry overall.
So, whether you’re looking for your next job in Europe, Asia, or North America, we invite you to explore our life sciences jobs and find out where your next career move could take you.